In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Merck & Co (NYSE:MRK) in comparison to its major competitors within the Pharmaceuticals industry. By analyzing crucial financial metrics, market position, and growth potential, our objective is to provide valuable insights for investors and offer a deeper understanding of company's performance in the industry.
Merck & Co Background
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Company | P/E | P/B | P/S | ROE | EBITDA (in billions) | Gross Profit (in billions) | Revenue Growth |
---|---|---|---|---|---|---|---|
Merck & Co Inc | 142.11 | 8.03 | 5.30 | 12.22% | $6.96 | $12.23 | 8.89% |
Eli Lilly and Co | 134.66 | 64.26 | 22.99 | 19.02% | $3.12 | $7.09 | 25.98% |
Novo Nordisk A/S | 50.88 | 45.61 | 18.60 | 24.73% | $36.91 | $55.43 | 22.45% |
Johnson & Johnson | 21.76 | 5.03 | 4.30 | 4.69% | $5.68 | $14.87 | 2.34% |
AstraZeneca PLC | 38.49 | 6.45 | 5.11 | 5.69% | $4.47 | $10.46 | 16.55% |
Novartis AG | 24.21 | 5.48 | 4.63 | 6.23% | $4.66 | $9.02 | 9.71% |
Zoetis Inc | 33.25 | 15.57 | 9.11 | 11.91% | $0.93 | $1.55 | 9.5% |
GSK PLC | 13.95 | 4.47 | 2.03 | 7.69% | $2.07 | $5.39 | 5.93% |
Takeda Pharmaceutical Co Ltd | 45.90 | 0.90 | 1.55 | -0.04% | $86.09 | $668.37 | 9.91% |
Dr Reddy's Laboratories Ltd | 18.84 | 3.74 | 3.76 | 4.77% | $20.32 | $41.48 | 12.49% |
Jazz Pharmaceuticals PLC | 22.04 | 1.82 | 1.92 | -0.39% | $0.23 | $0.81 | 1.03% |
Corcept Therapeutics Inc | 31.11 | 6.21 | 6.89 | 5.22% | $0.03 | $0.14 | 38.95% |
Prestige Consumer Healthcare Inc | 16.25 | 2.04 | 3.02 | 3.04% | $0.09 | $0.15 | -3.11% |
Average | 37.61 | 13.47 | 6.99 | 7.71% | $13.72 | $67.9 | 12.64% |